MétaCan
Menu
Back to cohort
Record W3119443482 · doi:10.1038/s41391-020-00311-2

Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer

2021· article· en· W3119443482 on OpenAlexafffund
Roshan Karunamuni, Minh‐Phuong Huynh‐Le, Chun Chieh Fan, Wesley K. Thompson, Rosalind A. Eeles, Zsofia Kote‐Jarai, Kenneth Muir, Artitaya Lophatananon, Johanna Schleutker, Nora Pashayan, Jyotsna Batra, Henrik Grönberg, Eleanor Walsh, Emma L. Turner, J. Athene Lane, Richard M. Martin, David E. Neal, Jenny Donovan, Freddie C. Hamdy, Børge G. Nordestgaard, Catherine M. Tangen, Robert J. MacInnis, Alicja Wolk, Demetrius Albanes, Christopher A. Haiman, Ruth C. Travis, Janet L. Stanford, Lorelei A. Mucci, Catharine West, Sune F. Nielsen, Adam S. Kibel, Fredrik Wiklund, Olivier Cussenot, Sonja I. Berndt, Stella Koutros, Karina D. Sørensen, Cezary Cybulski, Eli Marie Grindedal, Jong Y. Park, Sue A. Ingles, Christiane Maier, Robert J. Hamilton, Barry S. Rosenstein, Ana Vega, Manolis Kogevinas, Kathryn L. Penney, Manuel R. Teixeira, Hermann Brenner, Esther M. John, Radka Kaneva, Christopher J. Logothetis, Susan L. Neuhausen, Azad Hassan Abdul Razack, Lisa F. Newcomb, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Domínguez, Paul A. Townsend, Monique J. Roobol, Wei Zheng, Ian G. Mills, Ole A. Andreassen, Anders M. Dale, Tyler M. Seibert

Bibliographic record

VenueProstate Cancer and Prostatic Diseases · 2021
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Diagnosis and Treatment
Canadian institutionsUniversity of AlbertaPrincess Margaret Cancer CentreUniversity of Toronto
FundersDivision of Cancer Epidemiology and Genetics, National Cancer InstituteNational Cancer InstituteDepartament d'Universitats, Recerca i Societat de la InformacióXarxa de Bancs de Tumors de CatalunyaCancer Council TasmaniaWorld Cancer Research FundProstate Cancer FoundationMedical Research CouncilCanadian Cancer Society Research InstituteManchester Biomedical Research CentreNational Institutes of HealthDOD Prostate Cancer Research ProgramHellenic Health FoundationInstituto de Salud Carlos IIITaysNational Institute of Biomedical Imaging and BioengineeringCancer Council VictoriaUniversity of OxfordDeutsche KrebshilfeNational Health and Medical Research CouncilUniversiti MalayaHealth Technology Assessment ProgrammeProstate Cancer Foundation of AustraliaVetenskapsrådetKU LeuvenCanadian Institutes of Health ResearchBulgarian National Science FundCancerfondenFonds Wetenschappelijk OnderzoekVlaamse regeringNational Institute for Health and Care ResearchGentofte HospitalBundesministerium für Bildung und ForschungOvarian Cancer Research FundProstate Cancer CanadaCancer AustraliaAustralian GovernmentNorges ForskningsrådSwedish Cancer FoundationFundação para a Ciência e a TecnologiaZonMwU.S. Department of DefenseCancer Research UKCancer Research Coordinating CommitteeRoyal Marsden NHS Foundation TrustNational Cancer Research InstituteFundación Marqués de ValdecillaDeutsches KrebsforschungszentrumCancer Research InstituteEuropean CommissionAssociazione Italiana per la Ricerca sul CancroBreast Cancer Research Foundation
KeywordsMedicineProstate cancerRisk stratificationSingle-nucleotide polymorphismOncologyInternal medicinePolygenic risk scoreHazard ratioStratification (seeds)CancerGenotypeGeneticsGeneBiology

Abstract

fetched live from OpenAlex

BACKGROUND: Polygenic hazard scores (PHS) can identify individuals with increased risk of prostate cancer. We estimated the benefit of additional SNPs on performance of a previously validated PHS (PHS46). MATERIALS AND METHOD: 180 SNPs, shown to be previously associated with prostate cancer, were used to develop a PHS model in men with European ancestry. A machine-learning approach, LASSO-regularized Cox regression, was used to select SNPs and to estimate their coefficients in the training set (75,596 men). Performance of the resulting model was evaluated in the testing/validation set (6,411 men) with two metrics: (1) hazard ratios (HRs) and (2) positive predictive value (PPV) of prostate-specific antigen (PSA) testing. HRs were estimated between individuals with PHS in the top 5% to those in the middle 40% (HR95/50), top 20% to bottom 20% (HR80/20), and bottom 20% to middle 40% (HR20/50). PPV was calculated for the top 20% (PPV80) and top 5% (PPV95) of PHS as the fraction of individuals with elevated PSA that were diagnosed with clinically significant prostate cancer on biopsy. RESULTS: 166 SNPs had non-zero coefficients in the Cox model (PHS166). All HR metrics showed significant improvements for PHS166 compared to PHS46: HR95/50 increased from 3.72 to 5.09, HR80/20 increased from 6.12 to 9.45, and HR20/50 decreased from 0.41 to 0.34. By contrast, no significant differences were observed in PPV of PSA testing for clinically significant prostate cancer. CONCLUSIONS: Incorporating 120 additional SNPs (PHS166 vs PHS46) significantly improved HRs for prostate cancer, while PPV of PSA testing remained the same.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.472
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.293
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueProstate Cancer and Prostatic DiseasesSame topicProstate Cancer Diagnosis and TreatmentFrench-language works237,207